Please login to the form below

Not currently logged in

Novo Nordisk opens insulin facility in Russia

It will focus on new modern insulin formulation and filling

Novo Nordisk flag 

Novo Nordisk has opened a new modern insulin formulation and filling facility in Russia for the treatment of diabetes.

The facility, which opened on April 10, is located in Technopark Grabtsevo in the Kaluga region of the country.

Its production will cover Penfill cartridges and FlexPen prefilled insulin injection pens for the Russian market.

Lars Rebien Sørensen, CEO at Novo Nordisk, commented: “The manufacturing facility in Kaluga is a sign of our long-term commitment to people with diabetes in Russia, where close to 10 million people have the disease according to local studies.

“With our investment in local manufacturing, we ensure availability of high-quality modern insulins to the people with diabetes in Russia who rely on our products every day.”

The new arm is Russia's first greenfield facility for the manufacturing of modern insulin, with environmental targets for carbon dioxide emission, water consumption and use of energy having already been confirmed.

The construction of the new facility has so far created around 150 jobs.

Anatoly Artamonov, Russian governor for the Kaluga region, added: “I am convinced that the new facility will have a significant impact on improving the quality of life for people with diabetes in Kaluga as well as in the rest of Russia.”

Last month, the firm revealed plans to resubmit its FDA marketing applications for diabetes therapies Tresiba and Ryzodeg after being rejected two years ago, with the regulatory body beginning its revaluation last week.

Article by
Kirstie Pickering

14th April 2015

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
EY Life Sciences

Our global reach Against a backdrop of regulatory, digital, financial and global transformation, Life Sciences companies are finding integration and...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...